Ignite Creation Date:
2024-05-05 @ 10:55 PM
Last Modification Date:
2024-10-26 @ 10:26 AM
Study NCT ID:
NCT01218568
Status:
COMPLETED
Last Update Posted:
2013-04-04
First Post:
2010-10-05
Brief Title:
Rifaximin Plus Lactulose Versus Lactulose Alone for the Treatment of Hepatic Encephalopathy a Double Blind Randomized Trial
Sponsor:
Institute of Liver and Biliary Sciences India
Organization:
Institute of Liver and Biliary Sciences India
Organization Data
Organization:
Institute of Liver and Biliary Sciences India
Class:
OTHER
Study ID:
ILBS HE-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Institute of Liver and Biliary Sciences India
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None